183
Participants
Start Date
September 20, 2018
Primary Completion Date
September 14, 2022
Study Completion Date
September 14, 2022
Clesrovimab
Single ascending doses of clesrovimab will be administered via IM injection.
Placebo
Placebo (0.9% sodium chloride \[NaCl\]) will be administered via IM injection.
Chris Hani Baragwanath Academic Hospital ( Site 0262), Johannesburg
Tygerberg Hospital ( Site 0261), Cape Town
SUNY Upstate Medical University Hospital ( Site 0029), Syracuse
Hospital Clinico Universitario de Santiago ( Site 0241), Santiago de Compostela
WakeMed Health and Hospitals ( Site 0033), Raleigh
Hospital Universitario La Paz ( Site 0242), Madrid
Coastal Pediatric Research ( Site 0028), Charleston
Tribe Clinical Research, LLC ( Site 0082), Greenville
Next Phase Research Alliance, LLC ( Site 0075), Homestead
Acevedo Clinical Research Associates ( Site 0025), Miami
Cincinnati Children's Hospital Medical Center ( Site 0031), Cincinnati
Ohio Pediatric Research Association ( Site 0066), Dayton
University of Wisconsin American Family Children's Hospital ( Site 0068), Madison
Children's Mercy Hospital ( Site 0037), Kansas City
Cotton-O'Neil Clinical Research Center PediatricCare ( Site 0081), Topeka
University of Texas Medical Branch at Galveston ( Site 0039), Galveston
Tekton Research, Inc. ( Site 0026), San Antonio
Children's Hospital - Colorado ( Site 0067), Aurora
Kapiolani Medical Center for Women and Children ( Site 0027), Honolulu
Multicare Institute For Research And Innovation ( Site 0035), Tacoma
MedPlus Medicina Prepagada S.A. ( Site 0095), Bogotá
Fundacion Universitaria de Ciencias de la Salud - Sociedad de Cirugia ( Site 0099), Bogotá
Centro de Atención e Investigación Médica SAS - CAIMED CHIA ( Site 0100), Chía
Fundacion Valle del Lili ( Site 0090), Santiago de Cali
Centro de Investigacion Clinica Bradford Hill ( Site 0103), Santiago
Hospital La Florida ( Site 0050), Santiago
Facultad Medicina Universidad de Chile ( Site 0104), Santiago
Hospital Padre Hurtado ( Site 0102), Santiago
Dartmouth-Hitchcock Medical Center ( Site 0032), Lebanon
Fundacion Hospital San Vicente de Paul ( Site 0097), Medellín
Universidad Pontificia Bolivariana - Clinica Universitaria Bolivariana ( Site 0098), Medellín
Seoul National University Hospital ( Site 0071), Seoul
Severance Hospital Yonsei University Health System ( Site 0073), Seoul
Samsung Medical Center ( Site 0072), Seoul
Merck Sharp & Dohme LLC
INDUSTRY